摘要： Researchers hope the system can zero in on the right patients to enroll in clinical trials, to speed discovery of drug treatments.
A new model developed at MIT can help predict if patients at risk for Alzheimer’s disease will experience clinically significant cognitive decline due to the disease, by predicting their cognition test scores up to two years in the future.
The model could be used to improve the selection of candidate drugs and participant cohorts for clinical trials, which have been notoriously unsuccessful thus far. It would also let patients know they may experience rapid cognitive decline in the coming months and years, so they and their loved ones can prepare.
Link to Full Text： MIT News
若喜歡本文，請關注我們的臉書 Please Like our Facebook Page： Big Data In Finance